[go: up one dir, main page]

BR9602024A - Method for inhibiting the photo-decomposition of a compressed compound and capsule comprising a pharmaceutically active ingredient - Google Patents

Method for inhibiting the photo-decomposition of a compressed compound and capsule comprising a pharmaceutically active ingredient

Info

Publication number
BR9602024A
BR9602024A BR9602024A BR9602024A BR9602024A BR 9602024 A BR9602024 A BR 9602024A BR 9602024 A BR9602024 A BR 9602024A BR 9602024 A BR9602024 A BR 9602024A BR 9602024 A BR9602024 A BR 9602024A
Authority
BR
Brazil
Prior art keywords
capsule
inhibiting
photo
decomposition
active ingredient
Prior art date
Application number
BR9602024A
Other languages
Portuguese (pt)
Inventor
Willard C Newlin Jr
Sharon M Laughlin
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of BR9602024A publication Critical patent/BR9602024A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4883—Capsule finishing, e.g. dyeing, aromatising, polishing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Polymerisation Methods In General (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
BR9602024A 1995-04-24 1996-04-24 Method for inhibiting the photo-decomposition of a compressed compound and capsule comprising a pharmaceutically active ingredient BR9602024A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB1995/000287 WO1996033701A1 (en) 1995-04-24 1995-04-24 Inhibiting photodecomposition of 3-substituted-2-oxindoles

Publications (1)

Publication Number Publication Date
BR9602024A true BR9602024A (en) 1998-10-06

Family

ID=36997502

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9602024A BR9602024A (en) 1995-04-24 1996-04-24 Method for inhibiting the photo-decomposition of a compressed compound and capsule comprising a pharmaceutically active ingredient

Country Status (30)

Country Link
EP (1) EP0827399A1 (en)
JP (1) JPH10506635A (en)
KR (1) KR100189585B1 (en)
CN (1) CN1053667C (en)
AP (1) AP607A (en)
AR (1) AR002728A1 (en)
AU (1) AU692378B2 (en)
BG (1) BG100531A (en)
BR (1) BR9602024A (en)
CO (1) CO4700418A1 (en)
FI (1) FI973988A0 (en)
HR (1) HRP960194A2 (en)
HU (1) HU216544B (en)
IL (1) IL117969A0 (en)
IS (1) IS4339A (en)
MA (1) MA23848A1 (en)
NO (1) NO961622L (en)
NZ (1) NZ286432A (en)
OA (1) OA10286A (en)
PE (1) PE34397A1 (en)
RO (1) RO113305B1 (en)
RU (1) RU2109510C1 (en)
SG (1) SG64924A1 (en)
SI (1) SI9600133A (en)
SK (1) SK51296A3 (en)
TR (1) TR199600300A2 (en)
UA (1) UA42739C2 (en)
WO (1) WO1996033701A1 (en)
YU (1) YU25096A (en)
ZA (1) ZA963210B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11246323B2 (en) 2017-12-29 2022-02-15 Kraft Foods Group Brands Llc Oxidative stability of oil-in-water emulsions using natural stabilizers

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3136282A1 (en) * 1981-09-12 1983-03-24 Hoechst Ag "METHOD FOR STABILIZING PHOTO-UNSTABLE MEDICINAL PRODUCTS AND STABILIZED MEDICAL PREPARATIONS"
HUT59592A (en) * 1990-07-20 1992-06-29 Egyt Gyogyszervegyeszeti Gyar Process for the preparation of solid medical products
TW438798B (en) * 1992-10-07 2001-06-07 Pfizer 3-substituted 2-oxindole-1-carboxamide pharmaceutical compositions

Also Published As

Publication number Publication date
NO961622L (en) 1996-10-25
NZ286432A (en) 1998-05-27
TR199600300A2 (en) 1996-11-21
EP0827399A1 (en) 1998-03-11
OA10286A (en) 1997-09-19
KR960037656A (en) 1996-11-19
CN1139110A (en) 1997-01-01
HUP9601057A3 (en) 1997-05-28
HUP9601057A2 (en) 1997-04-28
ZA963210B (en) 1997-10-23
FI973988L (en) 1997-10-17
FI973988A7 (en) 1997-10-17
FI973988A0 (en) 1997-10-17
JPH10506635A (en) 1998-06-30
AP607A (en) 1997-08-27
AP9600787A0 (en) 1996-04-30
AR002728A1 (en) 1998-04-29
PE34397A1 (en) 1997-09-29
NO961622D0 (en) 1996-04-23
IL117969A0 (en) 1996-08-04
IS4339A (en) 1996-10-25
KR100189585B1 (en) 1999-06-01
MA23848A1 (en) 1996-12-31
HRP960194A2 (en) 1998-02-28
RU2109510C1 (en) 1998-04-27
AU692378B2 (en) 1998-06-04
BG100531A (en) 1997-06-30
RO113305B1 (en) 1998-06-30
CO4700418A1 (en) 1998-12-29
WO1996033701A1 (en) 1996-10-31
HU216544B (en) 1999-07-28
HU9601057D0 (en) 1996-06-28
AU5085196A (en) 1996-11-07
SI9600133A (en) 1996-10-31
UA42739C2 (en) 2001-11-15
YU25096A (en) 1998-08-14
CN1053667C (en) 2000-06-21
SK51296A3 (en) 1997-04-09
SG64924A1 (en) 1999-05-25

Similar Documents

Publication Publication Date Title
KR970006279A (en) 6-Dimethylaminomethyl-1-phenyl-cyclohexane compound as active pharmaceutical ingredient
CA2194167A1 (en) Hair-growing agent
FI973452L (en) Recorded dosage form for extended release of the active ingredient
EE03925B1 (en) Method for the preparation of a pharmacologically active substance
IL117728A (en) Pharmaceutical compositions for transdermal administration comprising an active principle a promotor and a solvent
HUP0004383A3 (en) Pharmaceutical preparation comprising clodronate as active ingredient and silicified microcrystalline cellulose as excipient
IL116673A0 (en) A pharmaceutical composition containing a benzimidazole derivative and processes for the preparation thereof
BR9600821A (en) Compound pharmaceutical formulation and process for the preparation of a compound
AU5538098A (en) A slow releasing physiologically active pharmaceutical and method of preparation thereof
AU7208494A (en) Controlled release of pharmaceutically active substances from coacervate microcapsules
BR9607095A (en) Compound pharmaceutical composition and processes for making and administering a compound
ZA988718B (en) Drug formulation having controlled release of active compound
HUT75029A (en) Systems for controlled release of pilocarpine, and semipermeable capsule containing the active ingredient
ZA9610714B (en) Rapid release tablet comprising tolfenamic acid or a pharmaceutically acceptable salt thereof as active ingredient and a method of preparing such tablet
ZA986320B (en) A method for the preparation of tertiary amines a compound useful therefor and alpha-2-receptor active tetrahyd-roisoquinoline derivatives
GB9526511D0 (en) Pharmaceutically active compounds
BR9602024A (en) Method for inhibiting the photo-decomposition of a compressed compound and capsule comprising a pharmaceutically active ingredient
FI972510A7 (en) Thiazolidinone compounds and a preparation containing them as an active ingredient for the treatment or prevention of angina pectoris
BR9606066A (en) Compound and pharmaceutical formulation
FI974601L (en) Peptide inhibiting the elevation of blood triglyceride levels and a blood triglyceride elevation inhibitor containing said peptide as an active ingredient
KR970000225A (en) Anti-depressant drug containing cinephrine as an active ingredient
ZA9810846B (en) An active hedgehog-protein-mutant a process for its preparation and its use for pharmaceutical purposes
AU6016496A (en) Antianginal drug comprising nitroxy derivative as active ingredient
IL112265A0 (en) Hydrazone compound and insecticide containing said compound as active ingredient
ZA95349B (en) Hydrazone compound and insecticide containing said compound as active ingredient

Legal Events

Date Code Title Description
FB34 Technical and formal requirements: requirement - article 34 of industrial property law
B11T Dismissal of application maintained [chapter 11.20 patent gazette]